Press Release Archive

09.23.2009

New Survey of People with Diabetic Nerve Pain Shows the Condition Significantly Impacts Daily Activities Such as Exercise and Sleep Yet Often Goes Untreated

09.21.2009

Pfizer Again Named To Working Mother 100 Best Companies List

09.21.2009

Survival Benefit Maintained in Long Term Follow-up of IES with Pfizer’s AROMASIN® (Exemestane Tablets)

09.21.2009

Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer Ingelheim

09.21.2009

Pfizer Commended For Leadership In Addressing Climate Change For Third Consecutive Year

09.18.2009

Pfizer To Present Research On Established Therapies And New Approaches To Cancer Treatment Using Investigational Agents

09.01.2009

Pfizer Concludes Previously Disclosed Settlement Agreement With U.S. Department Of Justice Regarding Past Promotional Practices

08.31.2009

Heading Back to School: Veterinarians Combine Stethoscopes with Microscopes

08.31.2009

Novel Biomarkers, Including CRP, Did Not Predict Risk Of Cardiovascular Events In Patients With Heart Disease Who Were Treated With A Statin

08.25.2009

Pfizer Inc Sponsors 7th Biennial U.S.–Africa Business Summit

08.22.2009

For Sixth Consecutive Year, Pfizer Earns Highest Score In Human Rights Campaign Foundation LGBT Ranking

08.18.2009

Pfizer And Private Access Announce Plans To Develop Online Community To Accelerate Clinical Research

08.05.2009

President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines for Patients with Drug-Resistant HIV in Developing Countries

07.29.2009

Pfizer, Kano State Reach Settlement Of Trovan Cases

07.29.2009

Pfizer And Medivation Initiate Phase 3 Trial Of Dimebon In Patients With Huntington Disease

07.28.2009

Pfizer and Fudan University Announce Joint Graduate Program in Clinical Research

07.28.2009

Pfizer Announces Partnership With Shanghai Institutes For Biological Sciences For Drug Discovery Activities

07.21.2009

Pfizer Reports Second-Quarter 2009 Results; Increases Full-Year 2009 Adjusted Diluted EPS(1) Guidance

07.20.2009

96-Week MERIT ES Analysis Shows Efficacy Of Pfizer’s HIV/AIDS Treatment Celsentri/Selzentry (Maraviroc) In Treatment-Naïve HIV Patients; Results Consistent With 48-Week Analysis

07.17.2009

Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth

07.14.2009

Pfizer Announces New Phase 1 Data From Two Novel Compounds For Alzheimer’s Disease At ICAD Annual Meeting

07.09.2009

Pfizer To Appeal Canadian Federal Court Decision On Company’s Norvasc® Patent

07.01.2009

Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer

07.01.2009

Pfizer Invites Public to Listen to Teleconference on Important Update Related to Chantix ® (varenicline)

06.30.2009

Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer

06.25.2009

Pfizer Declares a 16-Cent Third-Quarter 2009 Dividend

06.24.2009

Sutent Significantly Improved Progression-Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors

06.17.2009

Pfizer Invites Public to View and Listen to Webcast of July 22 Conference Call with Analysts

06.17.2009

Pfizer Registration Statement Relating To Pending Wyeth Acquisition Declared Effective By SEC

06.10.2009

Pfizer’s Oral JAK-3 Inhibitor Demonstrates Statistically Significant Response For Patients with Rheumatoid Arthritis, New Phase 2 Studies Show

06.02.2009

Pfizer Announces Completion Of European Debt Offering

06.02.2009

FDA Approves First Canine Cancer Therapy

06.01.2009

Pfizer Introduces New Treatment And Support Plan For Patients With Overactive Bladder

06.01.2009

Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast Cancer

05.30.2009

Pfizer Data Identify Certain Lung Cancer Patients Who May Benefit from Treatment with Figitumumab

05.29.2009

Pfizer Presents Data With Novel Investigational Agents In Select Patient Groups With Non-Small Cell Lung Cancer

05.29.2009

New Pfizer Data Helps to Identify Kidney Cancer Patients Who May Be Most Likely to Benefit from Treatment

05.29.2009

Pfizer Invites Public to View and Listen to Webcast of June 12 Conference Call with Analysts at EULAR

05.27.2009

Pfizer’s Sutent is Recommended for Reimbursement for Gastrointestinal Stromal Tumor Patients by British Health Agency

05.19.2009

Pfizer Expands Its Generics Portfolio Through Innovative Licensing Deals, Increasing Access To Medicines For Billions Worldwide

05.19.2009

Addition of Lyrica Significantly Improved Generalized Anxiety Disorder Symptoms in Patients Who Responded Only Partially to Previous GAD Treatments

05.19.2009

EU Commission Approves Pfizer Animal Health’s Vaccine Against Boar Taint

05.13.2009

Pfizer Launches Free Medicines Program For Newly Unemployed Americans

05.13.2009

Pfizer to Present New Clinical Data Highlighting Customized Treatment Approaches For Difficult-To-Treat Cancers

05.12.2009

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

05.12.2009

Greg Simon, Noted Leader In Health And Science Policy, Joins Pfizer

05.05.2009

Pfizer And Wisconsin Alumni Research Foundation (WARF) Sign License Agreement For Human Embryonic Stem Cells

05.04.2009

Dr. Freda Lewis-Hall Joins Pfizer As Chief Medical Officer